The diagnosis and treatment progress of olfaction disorders in chronic rhinosinusitis
-
摘要: 嗅觉障碍是慢性鼻窦炎患者的常见症状，其诊疗受到患者和医生的广泛关注。当前对于嗅觉障碍的评估及治疗方法众多，如何选择更为简便且准确的评估方法以及有效的治疗手段是临床难点。本文对近年来临床上常用的评估方法及治疗手段进行综述，以期对临床诊疗提供帮助。Abstract: Olfactory disorders are a common symptom in patients with chronic rhinosinusitis, and their diagnosis and treatment have garnered extensive attention from both patients and doctors. Currently, there are various evaluation and treatment methods for olfactory dysfunction; however, choosing a simpler and more accurate assessment, as well as an effective treatment, remains a clinical challenge. In this article, we review the assessment and treatment methods commonly used in clinical practice in recent years to provide better support for the diagnosis and treatment of olfactory disorders.
-
Key words:
- olfaction disorders /
- chronic rhinosinusitis /
- diagnosis /
- treatment
-
-
[1] Hirsch AG, Stewart WF, Sundaresan AS, et al. Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample[J]. Allergy, 2017, 72(2): 274-281.
[2] Haxel BR. Recovery of olfaction after sinus surgery for chronic rhinosinusitis: a review[J]. Laryngoscope, 2019, 129(5): 1053-1059. doi: 10.1002/lary.27764
[3] Kohli P, Naik AN, Harruff EE, et al. The prevalence of olfactory dysfunction in chronic rhinosinusitis[J]. Laryngoscope, 2017, 127(2): 309-320.
[4] Simopoulos E, Katotomichelakis M, Gouveris H, et al. Olfaction-associated quality of life in chronic rhinosinusitis: adaptation and validation of an olfaction-specific questionnaire[J]. Laryngoscope, 2012, 122(7): 1450-1454.
[5] Mattos JL, Bodner TE, Mace JC, et al. Psychometric properties of the brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2021, 11(10): 1436-1442.
[6] DeConde AS, Mace JC, Alt JA, et al. Longitudinal improvement and stability of the SNOT-22 survey in the evaluation of surgical management for chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2015, 5(3): 233-239.
[7] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 嗅觉障碍诊断和治疗专家共识(2017年)[J]. 中华耳鼻咽喉头颈外科杂志, 2018, 53(7): 484-494.
[8] Doty RL. Olfactory dysfunction and its measurement in the clinic[J]. World J Otorhinolaryngol Head Neck Surg, 2015, 1(1): 28-33.
[9] Aniteli MB, Marson FAL, Cunha FR, et al. Correlation and agreement of olfactory perception assessed by the Connecticut Chemosensory Clinical Research Center olfactory test and the Brief-Smell Identification Test[J]. Braz J Otorhinolaryngol, 2022, 88(6): 858-866.
[10] Soler ZM, Hyer JM, Karnezis TT, et al. The Olfactory Cleft Endoscopy Scale correlates with olfactory metrics in patients with chronic rhinosinusitis[J]. Int Forum Allergy Rhinol, 2016, 6(3): 293-298. doi: 10.1002/alr.21655
[11] Vandenhende-Szymanski C, Hochet B, Chevalier D, et al. Olfactory cleft opacity and CT score are predictive factors of smell recovery after surgery in nasal polyposis[J]. Rhinology, 2015, 53(1): 29-34. doi: 10.4193/Rhino14.160
[12] Kim BG, Kang JM, Shin JH, et al. Do sinus computed tomography findings predict olfactory dysfunction and its postoperative recovery in chronic rhinosinusitis patients?[J]. Am J Rhinol Allergy, 2015, 29(1): 69-76. doi: 10.2500/ajra.2015.29.4120
[13] 郭怡辰, 姚淋尹, 孙智甫, 等. 嗅球体积对上呼吸道感染后嗅觉障碍患者的预后评估[J]. 临床耳鼻咽喉头颈外科杂志, 2022, 36(1): 8-13.
[14] Kandemirli SG, Altundag A, Yildirim D, et al. Olfactory bulb MRI and paranasal sinus CT findings in persistent COVID-19 anosmia[J]. Acad Radiol, 2021, 28(1): 28-35. doi: 10.1016/j.acra.2020.10.006
[15] Gudziol V, Buschhüter D, Abolmaali N, et al. Increasing olfactory bulb volume due to treatment of chronic rhinosinusitis: a longitudinal study[J]. Brain, 2009, 132(Pt 11): 3096-3101.
[16] Zhang ZQ, Wu Y, Luo Q, et al. Regional homogeneity alterations of resting-state functional magnetic resonance imaging of chronic rhinosinusitis with olfactory dysfunction[J]. Front Neurosci, 2023, 17: 1146259.
[17] Hoekman PK, Houlton JJ, Seiden AM. The utility of magnetic resonance imaging in the diagnostic evaluation of idiopathic olfactory loss[J]. Laryngoscope, 2014, 124(2): 365-368. doi: 10.1002/lary.24248
[18] 刘佳, 占小俊, 姚淋尹, 等. 嗅觉障碍患者三叉神经事件相关电位的检测及临床意义[J]. 中华耳鼻咽喉头颈外科杂志, 2022, 57(8): 974-979.
[19] Banglawala SM, Oyer SL, Lohia S, et al. Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis[J]. Int Forum Allergy Rhinol, 2014, 4(12): 986-994. doi: 10.1002/alr.21373
[20] Baradaranfar MH, Ahmadi ZS, Dadgarnia MH, et al. Comparison of the effect of endoscopic sinus surgery versus medical therapy on olfaction in nasal polyposis[J]. Eur Arch Otorhinolaryngol, 2014, 271(2): 311-316. doi: 10.1007/s00405-013-2553-6
[21] Li P, Wang N, Kai L, et al. Chronic intranasal corticosteroid treatment induces degeneration of olfactory sensory neurons in normal and allergic rhinitis mice[J]. Int Forum Allergy Rhinol, 2023, 13(10): 1889-1905. doi: 10.1002/alr.23142
[22] Wallwork B, Coman W, Mackay-Sim A, et al. A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis[J]. Laryngoscope, 2006, 116(2): 189-193. doi: 10.1097/01.mlg.0000191560.53555.08
[23] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100.
[24] Guilemany JM, García-Piñero A, Alobid I, et al. The loss of smell in persistent allergic rhinitis is improved by levocetirizine due to reduction of nasal inflammation but not nasal congestion(the CIRANO study)[J]. Int Arch Allergy Immunol, 2012, 158(2): 184-190.
[25] Videler WJ, Badia L, Harvey RJ, et al. Lack of efficacy of long-term, low-dose azithromycin in chronic rhinosinusitis: a randomized controlled trial[J]. Allergy, 2011, 66(11): 1457-1468.
[26] Van Zele T, Gevaert P, Holtappels G, et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps[J]. J Allergy Clin Immunol, 2010, 125(5): 1069-1076.
[27] Mattos JL, Soler ZM, Schlosser RJ, et al. Olfactory function after surgical treatment of CRS: a comparison of CRS patients to healthy controls[J]. Am J Rhinol Allergy, 2021, 35(3): 391-398. doi: 10.1177/1945892420960671
[28] Jiang RS, Lu FJ, Liang KL, et al. Olfactory function in patients with chronic rhinosinusitis before and after functional endoscopic sinus surgery[J]. Am J Rhinol, 2008, 22(4): 445-448. doi: 10.2500/ajr.2008.22.3195
[29] Jiang RS, Su MC, Liang KL, et al. Preoperative prognostic factors for olfactory change after functional endoscopic sinus surgery[J]. Am J Rhinol Allergy, 2009, 23(1): 64-70. doi: 10.2500/ajra.2009.23.3262
[30] Chen FH, Zuo KJ, Guo YB, et al. Long-term results of endoscopic sinus surgery-oriented treatment for chronic rhinosinusitis with asthma[J]. Laryngoscope, 2014, 124(1): 24-28. doi: 10.1002/lary.24196
[31] van der Veen J, Seys SF, Timmermans M, et al. Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centre[J]. Allergy, 2017, 72(2): 282-290.
[32] Zhao R, Chen K, Tang YD. Olfactory changes after endoscopic sinus surgery for chronic rhinosinusitis: a meta-analysis[J]. Clin Otolaryngol, 2021, 46(1): 41-51.
[33] 刘承耀, 王向东, 司马宇彤, 等. 嗜酸粒细胞性鼻窦炎伴鼻息肉患者术后症状及体征变化在预测复发中的作用[J]. 临床耳鼻咽喉头颈外科杂志, 2023, 37(11): 864-870.
[34] Pade J, Hummel T. Olfactory function following nasal surgery[J]. Laryngoscope, 2008, 118(7): 1260-1264.
[35] Kim DW, Kim JY, Jeon SY. The status of the olfactory cleft may predict postoperative olfactory function in chronic rhinosinusitis with nasal polyposis[J]. Am J Rhinol Allergy, 2011, 25(2): e90-94.
[36] Zhang W, Meng YF, Wang CS, et al. Self-reported course of olfactory impairment determines outcome for successful surgical intervention in nasal polyps with anosmia[J]. Acta Otolaryngol, 2020, 140(12): 1021-1027.
[37] Gong SW, Ahmadi S, Blackburn SL, et al. Sniffin' sticks to measure olfactory function and recovery following bilateral superior turbinate resection as part of endoscopic transsphenoidal approach[J]. Ann Otol Rhinol Laryngol, 2021, 130(6): 636-642.
[38] 林海鹏, 李娜, 许彤, 等. 不保留中上鼻甲的内镜鼻窦手术对慢性鼻-鼻窦炎伴鼻息肉患者生存质量及嗅觉功能的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2016, 30(16): 1283-1286.
[39] Bardaranfar MH, Ranjbar Z, Dadgarnia MH, et al. The effect of an absorbable gelatin dressing impregnated with triamcinolone within the olfactory cleft on polypoid rhinosinusitis smell disorders[J]. Am J Rhinol Allergy, 2014, 28(2): 172-175.
[40] Gomes SC, Cavaliere C, Masieri S, et al. Reboot surgery for chronic rhinosinusitis with nasal polyposis: recurrence and smell kinetics[J]. Eur Arch Otorhinolaryngol, 2022, 279(12): 5691-5699.
[41] Saedi B, Sadeghi M, Yazdani N, et al. Effectiveness of FESS in smell improvement of sinusitis patients[J]. Indian J Otolaryngol Head Neck Surg, 2013, 65(Suppl 2): 283-287.
[42] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl S29): 1-464.
[43] Bachert C, Han JK, Wagenmann M, et al. EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps(CRSwNP)and biologics: Definitions and management[J]. J Allergy Clin Immunol, 2021, 147(1): 29-36.
[44] Bachert C, Marple B, Schlosser RJ, et al. Adult chronic rhinosinusitis[J]. Nat Rev Dis Primers, 2020, 6(1): 86.
[45] Liao B, Liu JX, Li ZY, et al. Multidimensional endotypes of chronic rhinosinusitis and their association with treatment outcomes[J]. Allergy, 2018, 73(7): 1459-1469.
[46] Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma[J]. J Allergy Clin Immunol, 2013, 131(1): 110-116.
[47] Barroso B, Valverde-Monge M, Alobid I, et al. Improvement in olfaction in patients with CRSwNP and severe asthma taking anti-IgE and anti-IL-5 biologics: a real-life study[J]. J Investig Allergol Clin Immunol, 2023, 33(1): 37-44.
[48] Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 MAb, as a treatment option for severe nasal polyposis[J]. J Allergy Clin Immunol, 2011, 128(5): 989-995.
[49] Bachert C, Sousa AR, Lund VJ, et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial[J]. J Allergy Clin Immunol, 2017, 140(4): 1024-1031.
[50] Han JK, Bachert C, Fokkens W, et al. Mepolizumab for chronic rhinosinusitis with nasal polyps(SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial[J]. Lancet Respir Med, 2021, 9(10): 1141-1153.
[51] Bagnasco D, Ferrando M, Varricchi G, et al. A critical evaluation of anti-IL-13 and anti-IL-4 strategies in severe asthma[J]. Int Arch Allergy Immunol, 2016, 170(2): 122-131.
[52] Bachert C, Mannent L, Naclerio RM, et al. Effect of subcutaneous dupilumab on nasal polyp burden in patients with chronic sinusitis and nasal polyposis: a randomized clinical trial[J]. JAMA, 2016, 315(5): 469-479.
[53] Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps(liberty np sinus-24 and liberty np sinus-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials[J]. Lancet, 2019, 394(10209): 1638-1650.
[54] De Corso E, Pasquini E, Trimarchi M, et al. Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps(CRSwNP): a multicentric observational Phase IV real-life study(DUPIREAL)[J]. Allergy, 2023, 78(10): 2669-2683.
[55] Oykhman P, Paramo FA, Bousquet J, et al. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: a systematic review and network meta-analysis[J]. J Allergy Clin Immunol, 2022, 149(4): 1286-1295.
[56] Bachert C, Zhang N, Holtappels G, et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma[J]. J Allergy Clin Immunol, 2010, 126(5): 962-968.
[57] Cao PP, Li HB, Wang BF, et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese[J]. J Allergy Clin Immunol, 2009, 124(3): 478-484.
[58] Hummel T, Rissom K, Reden J, et al. Effects of olfactory training in patients with olfactory loss[J]. Laryngoscope, 2009, 119(3): 496-499.
[59] Damm M, Pikart LK, Reimann H, et al. Olfactory training is helpful in postinfectious olfactory loss: a randomized, controlled, multicenter study[J]. Laryngoscope, 2014, 124(4): 826-831.
[60] Hwang SH, Kim SW, Basurrah MA, et al. The efficacy of olfactory training as a treatment for olfactory disorders caused by coronavirus disease-2019: a systematic review and meta-analysis[J]. Am J Rhinol Allergy, 2023, 37(4): 495-501.
[61] Haehner A, Tosch C, Wolz M, et al. Olfactory training in patients with Parkinson's disease[J]. PLoS One, 2013, 8(4): e61680.
[62] Whitcroft KL, Altundag A, Balungwe P, et al. Position paper on olfactory dysfunction: 2023[J]. Rhinology, 2023, 61(33): 1-108.
-
计量
- 文章访问数: 171
- 施引文献: 0
下载: